These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 2048426

  • 1. [Hemostatic changes associated with recombinant human erythropoietin (rHu Epo) treatment].
    Vinhas J, Assis P, Oliveira C, Crespo F, Prata MM.
    Acta Med Port; 1991; 4(1):9-12. PubMed ID: 2048426
    [Abstract] [Full Text] [Related]

  • 2. [Effects of the treatment with human recombinant erythropoietin on primary hemostasis in uremic patients].
    Cases A, Escolar G, Reverter JC, Garrido M, Ordinas A, López-Pedret J, Castillo R, Revert L.
    Med Clin (Barc); 1990 Nov 17; 95(17):644-7. PubMed ID: 2089202
    [Abstract] [Full Text] [Related]

  • 3. [Influence of long-term human recombinant erythropoietin treatment on secretion of pancreatic polypeptide and gastrin in hemodialysed patients with chronic renal failure].
    Nieszporek T, Kokot F, Wiecek A, Marcinkowski W, Rudka R, Trembecki J.
    Przegl Lek; 1995 Nov 17; 52(12):590-3. PubMed ID: 8834657
    [Abstract] [Full Text] [Related]

  • 4. [The effect of recombinant erythropoietin on candidicidal activity of polymorphonuclear leukocytes in hemodialyzed patients].
    Bartůnková J, Sulková S, Cebecauer M.
    Cas Lek Cesk; 1995 Dec 06; 134(23):756-9. PubMed ID: 8599817
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hypertension induced by recombinant human erythropoietin (rHU-EPO) can be prevented by indomethacin. Pathogenetic role of cytosolic calcium.
    Schiffl H, Lang SM.
    Eur J Med Res; 1997 Mar 24; 2(3):97-100. PubMed ID: 9113497
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients.
    Schiffl H, Lang SM.
    Nephrol Dial Transplant; 2006 Jan 24; 21(1):133-7. PubMed ID: 16144854
    [Abstract] [Full Text] [Related]

  • 12. Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group.
    Biggs JC, Atkinson KA, Booker V, Concannon A, Dart GW, Dodds A, Downs K, Szer J, Turner J, Worthington R.
    Bone Marrow Transplant; 1995 Jan 24; 15(1):129-34. PubMed ID: 7742745
    [Abstract] [Full Text] [Related]

  • 13. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
    Stasko J, Galajda P, Ivanková J, Hollý P, Rozborilová E, Kubisz P.
    Clin Appl Thromb Hemost; 2007 Oct 24; 13(4):410-5. PubMed ID: 17911193
    [Abstract] [Full Text] [Related]

  • 14. Enhanced platelet reactivity with erythropoietin but not following transfusion in dialysis patients.
    Roger SD, Piper J, Tucker B, Raine AE, Baker LR, Kovacs IB.
    Nephrol Dial Transplant; 1993 Oct 24; 8(3):213-7. PubMed ID: 8385286
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effectiveness of and tolerance to human recombinant erythropoietin in the treatment of kidney failure anemia in children undergoing continuous peritoneal dialysis. Multicenter study].
    Parchoux B, Broyer M, Cochat P, Burguet A, Menget A, Benoît D, Nivet H, Fischbach M, Geisert J, Dabout D.
    Pediatrie; 1993 Oct 24; 48(5):397-401. PubMed ID: 7777395
    [Abstract] [Full Text] [Related]

  • 17. [An experimental study of recombinant human erythropoietin on the treatment of acute myocardial infarction in rats].
    Ye L, Du XL, Xia JH, Jiang P, Wang JT, Fan HM, Liu ZM.
    Zhonghua Yi Xue Za Zhi; 2006 Oct 24; 86(39):2776-80. PubMed ID: 17199998
    [Abstract] [Full Text] [Related]

  • 18. Modulation of hematopoiesis by ketanserin in erythropoietin-treated uremic patients: evidence from platelet studies.
    Borawski J, Rydzewski A, Azzadin A, Buczko W, Mysliwiec M.
    Platelets; 1998 Oct 24; 9(1):31-5. PubMed ID: 16793742
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar 24; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.